We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
276
Alphabet (Google) Class C
GOOG
$4.52T
$11.9M 0.09%
168,240
-40,000
-19% -$2.7M
GOOGL icon
277
Alphabet (Google) Class A
GOOGL
$4.52T
$11.8M 0.09%
166,280
-44,000
-21% -$2.97M
PYPL icon
278
PayPal
PYPL
$49.2B
$11.8M 0.09%
67,600
-4,700
-7% -$650K
QURE icon
279
uniQure
QURE
$3.09B
$11.8M 0.09%
260,953
-26,162
-9% -$1.55M
PUK icon
280
Prudential
PUK
$37.4B
$11.7M 0.09%
396,259
-17,611
-4% -$466K
ADC icon
281
Agree Realty
ADC
$9.27B
$11.4M 0.09%
173,275
+116,550
+205% +$7.44M
BWXT icon
282
BWX Technologies
BWXT
$15.8B
$11.3M 0.09%
199,325
-12,025
-6% -$672K
CNMD icon
283
CONMED
CNMD
$1.55B
$11.3M 0.09%
156,532
UHAL icon
284
U-Haul Holding Co
UHAL
$13.9B
$11M 0.09%
365,000
HIG icon
285
Hartford Financial Services
HIG
$39B
$11M 0.08%
285,625
-105,125
-27% -$4.01M
NTRA icon
286
Natera
NTRA
$38.4B
$11M 0.08%
+220,611
New +$8.86M
IOVA icon
287
Iovance Biotherapeutics
IOVA
$1.88B
$10.8M 0.08%
+393,858
New +$12.9M
SYY icon
288
Sysco
SYY
$40.5B
$10.7M 0.08%
196,602
-57,529
-23% -$3.02M
MYOK
289
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10.7M 0.08%
+110,338
New +$9.2M
BHP icon
290
BHP
BHP
$212B
$10.3M 0.08%
231,100
-22,847
-9% -$894K
HON icon
291
Honeywell
HON
$78.3B
$10.2M 0.08%
74,753
-58,192
-44% -$7.7M
TFC icon
292
Truist Financial
TFC
$62.7B
$10.1M 0.08%
269,027
-12,262
-4% -$442K
CIB icon
293
Grupo Cibest SA
CIB
$21.6B
$9.77M 0.08%
371,265
+148,365
+67% +$3.89M
AFL icon
294
Aflac
AFL
$64.7B
$9.76M 0.08%
270,855
+33,613
+14% +$1.21M
TREE icon
295
LendingTree
TREE
$454M
$9.63M 0.07%
33,242
+6,454
+24% +$1.56M
AVGO icon
296
Broadcom
AVGO
$1.84T
$9.61M 0.07%
304,410
+225,410
+285% +$6.31M
EG icon
297
Everest Group
EG
$14.5B
$9.54M 0.07%
+46,275
New +$9.01M
ADBE icon
298
Adobe
ADBE
$100B
$9.45M 0.07%
21,700
-1,400
-6% -$519K
ICPT
299
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$9.43M 0.07%
+196,877
New +$15.2M
DAR icon
300
Darling Ingredients
DAR
$9.61B
$9.43M 0.07%
383,071

Similar funds

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.